Are 5-HT3antagonists effective in obsessive-compulsive disorder? A systematic review of literature-Reference-Cited by-同舟云学术

Are 5-HT3antagonists effective in obsessive-compulsive disorder? A systematic review of literature

Published:2015-02-10 Issue:2 Volume:30 Page:70-84
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol Clin Exp

Author:

Serata Daniele¹²,Kotzalidis Georgios D.¹,Rapinesi Chiara¹²,Janiri Delfina¹,Di Pietro Simone¹,Callovini Gemma¹,Piacentino Daria¹,Gasperoni Carlotta¹,Brugnoli Roberto¹,Ferri Vittoria Rachele¹,Girardi Nicoletta¹,Tatarelli Roberto¹,Ferracuti Stefano¹,Angeletti Gloria¹,Girardi Paolo¹²,Del Casale Antonio¹³

Affiliation:

1. Neurosciences, Mental Health, and Sensory Organs (NeSMOS) Department, School of Medicine and Psychology; Sapienza University of Rome, UOC Psychiatry, Sant'Andrea Hospital; Roma Italy

2. Department of Neuropsychiatry; Villa Rosa Suore Ospedaliere of the Sacred Heart of Jesus; Viterbo Italy

3. Department of Psychiatric Rehabilitation; P. Alberto Mileno Onlus Foundation, San Francesco Institute; Vasto Chieti Italy

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology

Reference150 articles.

1. Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder;Ackerman;J Clin Psychopharmacol,2002

2. Animal models of obsessive-compulsive disorder: exploring pharmacology and neural substrates;Albelda;Neurosci Biobehav Rev,2012a

3. Current animal models of obsessive compulsive disorder: an update;Albelda;Neuroscience,2012b

4. The role of NMDA receptors in the signal attenuation rat model of obsessive-compulsive disorder;Albelda;Psychopharmacology (Berl),2010

5. Quinpirole and 8-OH-DPAT induce compulsive checking behavior in male rats by acting on different functional parts of an OCD neurocircuit;Alkhatib;Behav Pharmacol,2013

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psilocybin in pharmacotherapy of obsessive-compulsive disorder;Pharmacological Reports;2024-08-01

2. Role of 5-hydroxytryptamine type 3 receptors in the regulation of anxiety reactions;Journal of Zhejiang University-SCIENCE B;2024-01

3. Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive–compulsive disorder: a systematic review and meta-analysis of randomized clinical trials;Scientific Reports;2023-11-27

4. A closer look to neural pathways and psychopharmacology of obsessive compulsive disorder;Frontiers in Behavioral Neuroscience;2023-11-16

5. Tourette syndrome and obsessive-compulsive disorder: A comprehensive review of structural alterations and neurological mechanisms;Behavioural Brain Research;2023-09